<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Alkem Laboratories Limited — News on 6ix</title>
<link>https://6ix.com/company/alkem-laboratories-limited</link>
<description>Latest news and press releases for Alkem Laboratories Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 07 Apr 2026 19:26:34 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/alkem-laboratories-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836481578dffbe2df151fbf.webp</url>
<title>Alkem Laboratories Limited</title>
<link>https://6ix.com/company/alkem-laboratories-limited</link>
</image>
<item>
<title>Press Release Apr 07 2026</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-apr-07-2026-17</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-apr-07-2026-17</guid>
<pubDate>Tue, 07 Apr 2026 19:26:34 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Alkem launches A to Z Daily, an everyday multivitamin supplement for body and mind".</description>
</item>
<item>
<title>Press Release Mar 21 2026</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-mar-21-2026-4</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-mar-21-2026-4</guid>
<pubDate>Sat, 21 Mar 2026 16:16:43 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Alkem Laboratories launches Semaglutide injection in India, with weekly therapy starting at INR 450/- ".</description>
</item>
<item>
<title>Press Release Mar 20 2026</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-mar-20-2026-3</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-mar-20-2026-3</guid>
<pubDate>Sat, 21 Mar 2026 01:18:04 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 20, 2026, titled "Intimation regarding receipt of EU GMP Certificate for the Company s manufacturing facility located at Daman, India".</description>
</item>
<item>
<title>Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/axsome-therapeutics-settles-sunosir-solriamfetol-patent-litigation-with-alkem-laboratories-ltd</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/axsome-therapeutics-settles-sunosir-solriamfetol-patent-litigation-with-alkem-laboratories-ltd</guid>
<pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
<description>NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a settlement agreement with Alkem Laboratories Ltd. (Alkem) resolving patent litigation related to Axsome’s product SUNOSI® (solriamfetol). The litigation, which is pending in the United States District Court for the District of New Jersey, resulted from sub</description>
</item>
<item>
<title>Press Release Feb 13 2026</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-feb-13-2026-5</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-feb-13-2026-5</guid>
<pubDate>Fri, 13 Feb 2026 19:38:30 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release".</description>
</item>
<item>
<title>Press Release Jan 08 2026</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-jan-08-2026-11</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-jan-08-2026-11</guid>
<pubDate>Thu, 08 Jan 2026 20:02:17 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated January 08, 2026, titled "Alkem launches Renocia cyclical therapy, a nutritional supplements kit, to support hair growth".</description>
</item>
<item>
<title>Press Release Nov 20 2025</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-nov-20-2025-5</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-nov-20-2025-5</guid>
<pubDate>Thu, 20 Nov 2025 21:56:17 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated November 20, 2025, titled "Press Release Alkem launches probiotic DSS , the original De Simone formulation, in India for gut health management".</description>
</item>
<item>
<title>Press Release (Revised) Nov 03 2025</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-revised-nov-03-2025</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-revised-nov-03-2025</guid>
<pubDate>Mon, 03 Nov 2025 19:24:15 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a revised press release dated November 03, 2025, titled "Alkem Foundation and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines".</description>
</item>
<item>
<title>Press Release Nov 03 2025</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-nov-03-2025-16</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-nov-03-2025-16</guid>
<pubDate>Mon, 03 Nov 2025 18:08:07 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated November 03, 2025, titled "Alkem and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines".</description>
</item>
<item>
<title>Press Release Sep 22 2025</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-sep-22-2025-7</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-sep-22-2025-7</guid>
<pubDate>Mon, 22 Sep 2025 20:01:17 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated September 22, 2025, titled "Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer.".</description>
</item>
<item>
<title>Press Release Aug 19 2025</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-aug-19-2025-9</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-aug-19-2025-9</guid>
<pubDate>Tue, 19 Aug 2025 17:00:53 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 19, 2025, titled "Alkem launches Olesoft Trucera, an advanced ceramide-boostingmoisturizing lotion for skin barrier repair.".</description>
</item>
<item>
<title>Press Release Mar 13 2025</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-mar-13-2025-5</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-mar-13-2025-5</guid>
<pubDate>Thu, 13 Mar 2025 20:16:09 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2025, titled "US FDA Inspection at Company s Bioequivalence Center located at Taloja".</description>
</item>
<item>
<title>Press Release Mar 12 2025</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-mar-12-2025-6</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-mar-12-2025-6</guid>
<pubDate>Wed, 12 Mar 2025 14:05:29 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 12, 2025, titled "Alkem launches generic empagliflozin and its combinations in India under the brand name Empanorm .".</description>
</item>
<item>
<title>Press Release Feb 04 2025</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-feb-04-2025-14</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-feb-04-2025-14</guid>
<pubDate>Tue, 04 Feb 2025 21:38:56 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated February 04, 2025, titled "Alkem Laboratories Limited has announced the launch of Kojiglo serum in India for managing facial hyperpigmentation.".</description>
</item>
<item>
<title>Press Release Oct 10 2024</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-oct-10-2024-10</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-oct-10-2024-10</guid>
<pubDate>Thu, 10 Oct 2024 18:12:01 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated October 10, 2024, titled "ALKEM signs a licensing agreement with M/s. Sonnet BioTherapeutics Holdings, Inc. to develop and commercialize SON-080 for Diabetic Peripheral Neuropathy in India.".</description>
</item>
<item>
<title>Press Release Sep 27 2024</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-sep-27-2024-7</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-sep-27-2024-7</guid>
<pubDate>Fri, 27 Sep 2024 18:36:42 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated September 27, 2024, titled "ALKEM denies claims of Pan-D, Clavam 625 batches being not-of-standard quality.".</description>
</item>
<item>
<title>Press Release Jun 25 2024</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-jun-25-2024-6</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-jun-25-2024-6</guid>
<pubDate>Tue, 25 Jun 2024 15:37:58 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 25, 2024, titled "Closure of US FDA Inspection at Company's manufacturing facility located at Baddi, India".</description>
</item>
<item>
<title>Press Release Mar 27 2024</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-mar-27-2024-5</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-mar-27-2024-5</guid>
<pubDate>Thu, 28 Mar 2024 00:29:01 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 27, 2024, titled "USFDA Inspection at Company s manufacturing facility located at Baddi, India".</description>
</item>
<item>
<title>Press Release Feb 28 2024</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-feb-28-2024-5</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-feb-28-2024-5</guid>
<pubDate>Wed, 28 Feb 2024 20:17:07 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated February 28, 2024, titled "Closure of US FDA Inspection at Company's API manufacturing facility located at Mandva.".</description>
</item>
<item>
<title>Press Release Dec 01 2023</title>
<link>https://6ix.com/company/alkem-laboratories-limited/news/press-release-dec-01-2023-9</link>
<guid isPermaLink="true">https://6ix.com/company/alkem-laboratories-limited/news/press-release-dec-01-2023-9</guid>
<pubDate>Sat, 02 Dec 2023 01:45:21 GMT</pubDate>
<description>Alkem Laboratories Limited has informed the Exchange regarding a press release dated December 01, 2023, titled "US FDA Inspection at Company s API manufacturing facility located at Mandva".</description>
</item>
</channel>
</rss>